Osaic Holdings’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-112
| Closed | -$10 | – | 7717 |
|
|
2024
Q2 | $10 | Sell |
112
-302
| -73% | -$246 | ﹤0.01% | 7360 |
|
|
2024
Q1 | $379 | Hold |
414
| – | – | ﹤0.01% | 6874 |
|
|
2023
Q4 | $847 | Hold |
414
| – | – | ﹤0.01% | 6804 |
|
|
2023
Q3 | $1.5K | Sell |
414
-4
| -1% | -$17 | ﹤0.01% | 6719 |
|
|
2023
Q2 | $1.95K | Sell |
418
-28
| -6% | -$137 | ﹤0.01% | 6673 |
|
|
2023
Q1 | $2.08K | Sell |
446
-26
| -6% | -$146 | ﹤0.01% | 6698 |
|
|
2022
Q4 | $1K | Sell |
472
-16
| -3% | -$103 | ﹤0.01% | 7061 |
|
|
2022
Q3 | $9K | Buy |
488
+36
| +8% | +$1.26K | ﹤0.01% | 6097 |
|
|
2022
Q2 | $23K | Buy |
452
+77
| +21% | +$5.73K | ﹤0.01% | 5532 |
|
|
2022
Q1 | $53K | Hold |
375
| – | – | ﹤0.01% | 5058 |
|
|
2021
Q4 | $64K | Sell |
375
-37
| -9% | -$13.8K | ﹤0.01% | 4962 |
|
|
2021
Q3 | $205K | Buy |
412
+21
| +5% | +$9.73K | ﹤0.01% | 3877 |
|
|
2021
Q2 | $196K | Sell |
391
-26
| -6% | -$14K | ﹤0.01% | 3879 |
|
|
2021
Q1 | $212K | Buy |
417
+1
| +0.2% | +$516 | ﹤0.01% | 3679 |
|
|
2020
Q4 | $198K | Buy |
416
+244
| +142% | +$80K | ﹤0.01% | 3497 |
|
|
2020
Q3 | $49K | Buy |
172
+83
| +93% | +$20.6K | ﹤0.01% | 4324 |
|
|
2020
Q2 | $17K | Sell |
89
-255
| -74% | -$42.4K | ﹤0.01% | 4902 |
|
|
2020
Q1 | $42K | Buy |
+344
| New | +$62.3K | ﹤0.01% | 4112 |
|
Osaic Holdings's AMPE Position: Q3 2024 in Review
Osaic Holdings sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2024, closing a stake of 112 shares — an estimated $10 sold.
Osaic Holdings first reported a position in AMPE in Q1 2020 and held it in 18 quarters. The position peaked at $212K in Q1 2021. 0 funds tracked by Wall St. Rank hold AMPE as of Q3 2024.
- Osaic Holdings reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 112 Ampio Pharmaceuticals Inc. shares in Q3 2024, an estimated $10.
- Osaic Holdings first reported a position in Ampio Pharmaceuticals Inc. in Q1 2020 and held it in 18 quarters.
- Osaic Holdings's Ampio Pharmaceuticals Inc. position peaked at $212K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.